The clinical outcome of adult Philadelphia (Ph)-positive acute lymphoblastic leukemia (ALL).

被引：0
|
作者：
Faderl, S
Kantajian, HM
Thomas, D
Cortes, J
Giles, F
Estrov, Z
机构：
[1] Univ Texas, MD Anderson Cancer Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Cancer Ctr, Dept Bioimmunotherapy, Houston, TX 77030 USA
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
922
引用
收藏
页码：225A / 225A
页数：1
相关论文
共 50 条
  • [31] Treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
    Ryuzo Ohno
    Current Oncology Reports, 2008, 10
  • [32] Outcome of treatment in children with philadelphia chromosome-positive acute lymphoblastic leukemia
    Aricò, M
    Valsecchi, MG
    Camitta, B
    Schrappe, M
    Chessells, J
    Baruchel, A
    Gaynon, P
    Silverman, L
    Janka-Schaub, G
    Kamps, W
    Pui, CH
    Masera, G
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (14): : 998 - 1006
  • [33] Treatment of Adult Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Ohno, Ryuzo
    CURRENT ONCOLOGY REPORTS, 2008, 10 (05) : 379 - 387
  • [34] OUTCOME OF ADULT PHILADELPHIA ACUTE LYMPHOBLASTIC LEUKEMIA IN THE IMATINIB ERA IN THE SOUTH OF TUNISIA
    Frikha, I.
    Medhaffer, M.
    Hadiji, S.
    Kassar, O.
    Mnif, S.
    Bellaaj, H.
    Ghorbel, M.
    Kallel, F.
    Ben Abdeljalil, N.
    Sennana, H.
    Elloumi, M.
    HAEMATOLOGICA, 2016, 101 : 664 - 664
  • [35] Clinical outcome of adult acute lymphoblastic leukemia based on Philadelphia chromosome status and socioeconomic status.
    Dao, Bao Duy
    Law, Jennie York
    Le, Phat
    Gao, Ang
    Ahn, Chul
    Kumar, Kirthi
    Anderson, Larry Don
    Collins, Robert
    Li, Hsiao Ching
    Patel, Prapti Arvind
    Sadeghi, Navid
    Vusirikala, Madhuri
    Naina, Harris V. K.
    Scaglioni, Pier P.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [36] Outcome with the hyper-CVAD and imatinib mesylate regimen as frontline therapy for adult Philadelphia (Ph) positive acute lymphocytic leukemia (ALL).
    Thomas, Deborah A.
    Kantarjian, Hagop M.
    Cortes, Jorge
    Faderl, Stefan
    Giles, Francis
    Garcia-Manero, Guillermo
    Wierda, William
    Ferrajoli, Alessandra
    Ravandi-Kashani, Farhad
    Verstovsek, Srdan
    Andreeff, Michael
    Letvak, Laurie A.
    Jones, Dan
    Champlin, Richard
    O'Brien, Susan
    BLOOD, 2006, 108 (11) : 87A - 88A
  • [37] Constitutive NF-κB/Rel activation in Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL)
    Munzert, G
    Kirchner, D
    Ottmann, O
    Bergmann, L
    Schmid, RM
    LEUKEMIA & LYMPHOMA, 2004, 45 (06) : 1181 - 1184
  • [38] Maxizyme, a novel ribozyme, induces cell death of Philadelphia chromosome positive acute lymphoblastic leukemia (Ph plus ALL).
    Soda, Y
    Tani, K
    Bai, YS
    Chen, MH
    Izawa, K
    Saiki, M
    Kuwabara, T
    Warashina, M
    Tanabe, T
    Miyoshi, H
    Sugita, K
    Nakazawa, S
    Tojo, A
    Taira, K
    Asano, S
    BLOOD, 2002, 100 (11) : 656A - 656A
  • [39] Discontinuation of Tyrosine Kinase Inhibitors (TKIs) in Philadelphia Chromosome-Positive (Ph plus ) Acute Lymphoblastic Leukemia (ALL)
    Samra, Bachar
    Kantarjian, Hagop M.
    Sasaki, Koji
    Konopleva, Marina Y.
    Khouri, Rita
    O'Brien, Susan M.
    Ferrajoli, Alessandra
    Nunez, Cesar
    Kadia, Tapan M.
    Jabbour, Elias
    BLOOD, 2019, 134
  • [40] Therapy of Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph+ALL) with inhibitor of the abl tyrosinkinase (Glivec)
    Ottmann, OG
    Wassmann, B
    Hoelzer, D
    MEDIZINISCHE KLINIK, 2002, 97 : 16 - 21
12345